SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study (2022)
Attributed to:
The impact of IFTIM3 genetic variation on Influenza virus infection, immune responses and disease outcome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2666-5247(22)00036-2
PubMed Identifier: 35345417
Publication URI: http://europepmc.org/abstract/MED/35345417
Type: Journal Article/Review
Parent Publication: The Lancet Microbe
Issue: 5
ISSN: 2666-5247